339 related articles for article (PubMed ID: 16809573)
1. Atrial fibrillation and stroke in the general medicare population: a 10-year perspective (1992 to 2002).
Lakshminarayan K; Solid CA; Collins AJ; Anderson DC; Herzog CA
Stroke; 2006 Aug; 37(8):1969-74. PubMed ID: 16809573
[TBL] [Abstract][Full Text] [Related]
2. Temporal trends in ischemic stroke and anticoagulation therapy for non-valvular atrial fibrillation: effect of diabetes.
Shroff GR; Solid CA; Bloomgarden Z; Halperin JL; Herzog CA
J Diabetes; 2017 Feb; 9(2):115-122. PubMed ID: 26929264
[TBL] [Abstract][Full Text] [Related]
3. Atrial fibrillation, stroke, and anticoagulation in Medicare beneficiaries: trends by age, sex, and race, 1992-2010.
Shroff GR; Solid CA; Herzog CA
J Am Heart Assoc; 2014 Jun; 3(3):e000756. PubMed ID: 24895161
[TBL] [Abstract][Full Text] [Related]
4. Cost efficiency of anticoagulation with warfarin to prevent stroke in medicare beneficiaries with nonvalvular atrial fibrillation.
Mercaldi CJ; Ciarametaro M; Hahn B; Chalissery G; Reynolds MW; Sander SD; Samsa GP; Matchar DB
Stroke; 2011 Jan; 42(1):112-8. PubMed ID: 21148442
[TBL] [Abstract][Full Text] [Related]
5. Outcomes After Warfarin Initiation in a Cohort of Hemodialysis Patients With Newly Diagnosed Atrial Fibrillation.
Shen JI; Montez-Rath ME; Lenihan CR; Turakhia MP; Chang TI; Winkelmayer WC
Am J Kidney Dis; 2015 Oct; 66(4):677-88. PubMed ID: 26162653
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness and safety of warfarin initiation in older hemodialysis patients with incident atrial fibrillation.
Winkelmayer WC; Liu J; Setoguchi S; Choudhry NK
Clin J Am Soc Nephrol; 2011 Nov; 6(11):2662-8. PubMed ID: 21959598
[TBL] [Abstract][Full Text] [Related]
7. Predictors of warfarin use in atrial fibrillation patients in the inpatient setting.
Agarwal S; Bennett D; Smith DJ
Am J Cardiovasc Drugs; 2010; 10(1):37-48. PubMed ID: 20104933
[TBL] [Abstract][Full Text] [Related]
8. Temporal trends in ischemic stroke and anticoagulation therapy among Medicare patients with atrial fibrillation: a 15-year perspective (1992-2007).
Shroff GR; Solid CA; Herzog CA
JAMA Intern Med; 2013 Jan; 173(2):159-60. PubMed ID: 23266657
[No Abstract] [Full Text] [Related]
9. Prevalence and quality of warfarin use for patients with atrial fibrillation in the long-term care setting.
McCormick D; Gurwitz JH; Goldberg RJ; Becker R; Tate JP; Elwell A; Radford MJ
Arch Intern Med; 2001 Nov; 161(20):2458-63. PubMed ID: 11700158
[TBL] [Abstract][Full Text] [Related]
10. Anticoagulation for stroke prevention in elderly patients with atrial fibrillation, including those with falls and/or early-stage dementia: a single-center, retrospective, observational study.
Jacobs LG; Billett HH; Freeman K; Dinglas C; Jumaquio L
Am J Geriatr Pharmacother; 2009 Jun; 7(3):159-66. PubMed ID: 19616184
[TBL] [Abstract][Full Text] [Related]
11. Atrial fibrillation, stroke risk, and warfarin therapy revisited: a population-based study.
Björck S; Palaszewski B; Friberg L; Bergfeldt L
Stroke; 2013 Nov; 44(11):3103-8. PubMed ID: 23982711
[TBL] [Abstract][Full Text] [Related]
12. The effect and safety of the antithrombotic therapies in patients with atrial fibrillation and CHADS score 1.
Lee BH; Park JS; Park JH; Park JS; Kwak JJ; Hwang ES; Kim SK; Choi DH; Kim YH; Pak HN
J Cardiovasc Electrophysiol; 2010 May; 21(5):501-7. PubMed ID: 20021521
[TBL] [Abstract][Full Text] [Related]
13. A risk score for predicting stroke or death in individuals with new-onset atrial fibrillation in the community: the Framingham Heart Study.
Wang TJ; Massaro JM; Levy D; Vasan RS; Wolf PA; D'Agostino RB; Larson MG; Kannel WB; Benjamin EJ
JAMA; 2003 Aug; 290(8):1049-56. PubMed ID: 12941677
[TBL] [Abstract][Full Text] [Related]
14. Current trial-associated outcomes with warfarin in prevention of stroke in patients with nonvalvular atrial fibrillation: a meta-analysis.
Agarwal S; Hachamovitch R; Menon V
Arch Intern Med; 2012 Apr; 172(8):623-31; discussion 631-3. PubMed ID: 22450212
[TBL] [Abstract][Full Text] [Related]
15. Net clinical benefit of antithrombotic therapy in patients with atrial fibrillation and chronic kidney disease: a nationwide observational cohort study.
Bonde AN; Lip GY; Kamper AL; Hansen PR; Lamberts M; Hommel K; Hansen ML; Gislason GH; Torp-Pedersen C; Olesen JB
J Am Coll Cardiol; 2014 Dec; 64(23):2471-82. PubMed ID: 25500231
[TBL] [Abstract][Full Text] [Related]
16. Outcomes Associated With Resuming Warfarin Treatment After Hemorrhagic Stroke or Traumatic Intracranial Hemorrhage in Patients With Atrial Fibrillation.
Nielsen PB; Larsen TB; Skjøth F; Lip GY
JAMA Intern Med; 2017 Apr; 177(4):563-570. PubMed ID: 28241151
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular, bleeding, and mortality risks in elderly Medicare patients treated with dabigatran or warfarin for nonvalvular atrial fibrillation.
Graham DJ; Reichman ME; Wernecke M; Zhang R; Southworth MR; Levenson M; Sheu TC; Mott K; Goulding MR; Houstoun M; MaCurdy TE; Worrall C; Kelman JA
Circulation; 2015 Jan; 131(2):157-64. PubMed ID: 25359164
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness and safety of dabigatran and warfarin in real-world US patients with non-valvular atrial fibrillation: a retrospective cohort study.
Lauffenburger JC; Farley JF; Gehi AK; Rhoney DH; Brookhart MA; Fang G
J Am Heart Assoc; 2015 Apr; 4(4):. PubMed ID: 25862791
[TBL] [Abstract][Full Text] [Related]
19. A comparison of the safety and effectiveness of dabigatran and warfarin in non-valvular atrial fibrillation patients in a large healthcare system.
Villines TC; Schnee J; Fraeman K; Siu K; Reynolds MW; Collins J; Schwartzman E
Thromb Haemost; 2015 Nov; 114(6):1290-8. PubMed ID: 26446456
[TBL] [Abstract][Full Text] [Related]
20. Relationship of Age With Stroke and Death in Anticoagulated Patients With Nonvalvular Atrial Fibrillation: AMADEUS Trial.
Senoo K; Lip GY
Stroke; 2015 Nov; 46(11):3202-7. PubMed ID: 26463692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]